HER3 protein overexpression has been shown to commonly co-occur with HER2 gene amplification and HER2 overexpression, therefore, HER3 is thought to contribute markedly to the pathogenesis of HER2-amplified breast cancer subtype [4, 13, 14]. Here, ERBB3 is linked to breast carcinoma.